Amlodipine Besylate Tablet
Product Images NDC 59762-2135

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 59762-2135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Amlodipine 01)

Chemical structure diagram of amlodipine besylate, showing its molecular framework including rings, functional groups, and atomic components.*

FDA Label Image

Figure 1 (Amlodipine 02)

A line graph depicting event rates over time (in months) comparing Amlodipine and Placebo groups. The graph shows lower event rates for Amlodipine throughout the study period, with numbers at risk listed below the time axis. A statistical inset displays a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval (0.54, 0.88).*

FDA Label Image

Figure 2 (Amlodipine 03)

A forest plot illustrating hazard ratios with 95% confidence intervals comparing the effects of amlodipine versus placebo across various patient subgroups including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent status. The plot shows the overall patient group and subgroups, with markers indicating favorability towards amlodipine or placebo.*

FDA Label Image

Logo (Amlodipine 04)

FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (5 mg Blister Pack)

Label for amlodipine besylate tablets 2.5 mg by Greenstone LLC. The label states 90 tablets in the package. It includes storage instructions, dosage form as oral tablets, and identifies the product as prescription only, distributed by Greenstone LLC in Peapack, NJ. The NDC is 59762-2242-9.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Label for amlodipine besylate tablets 5 mg, in a package containing 90 tablets. The product is branded as GREENSTONE® and labeled for prescription use only. The label includes storage instructions, dosage information specifying each tablet contains amlodipine besylate equivalent to 5 mg amlodipine, and distribution details by Greenstone LLC, Peapack, NJ. The label displays the NDC number 59762-2010-9.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Carton)

Label for Greenstone brand amlodipine besylate tablets, 10 mg strength, oral dosage form, in a bottle containing 90 tablets. The label includes storage instructions, dosage and use notes, and distributor information for Greenstone LLC, Peapack, NJ. It features the NDC 59762-2135-9 and highlights the prescription-only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.